Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | CA9 | Q16790 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | TAS2R46 | P59540 | 2/20 | 0.31 |
| ▸ | MAOA | P21397 | 1/20 | 0.30 |
| ▸ | PARP1 | P09874 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL44996 | 1.00 | CA1 (0.41) | CA1CA9SMN1; SMN2MEN1KMT2A | |
| SCHEMBL439067 | 1.00 | CA1 (0.41) | CA1CA9SMN1; SMN2MEN1KMT2A | |
| SCHEMBL682255 | 1.00 | CA1 (0.41) | CA1CA9SMN1; SMN2MEN1KMT2A | |
| SCHEMBL732959 | 1.00 | CA1 (0.41) | CA1CA9SMN1; SMN2MEN1KMT2A | |
| SCHEMBL15034 | 1.00 | CA1 (0.41) | CA1CA9SMN1; SMN2MEN1KMT2A | |
| SCHEMBL15195848 | 1.00 | CA1 (0.41) | CA1CA9SMN1; SMN2MEN1KMT2A | |
| SCHEMBL2860232 | 1.00 | CA1 (0.41) | CA1CA9SMN1; SMN2MEN1KMT2A | |
| Methane SCHEMBL1276943 | 0.96 | CA1 (0.39) | CA1CA9SMN1; SMN2MEN1KMT2A | |
| SCHEMBL2314693 | 0.96 | CA1 (0.39) | CA1CA9SMN1; SMN2MEN1KMT2A | |
| Ammonia Solution, Strong SCHEMBL17351919 | 0.96 | CA1 (0.39) | CA1CA9SMN1; SMN2MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109627463-A | Hydrogel and pharmaceutical grade protein | 深圳诺坦药物技术有限公司 | 2019-04-16 | — | — | CN | claimed |
| CN-107320782-B | Absorbable bio-medical lactic acid composite material and preparation method thereof | 深圳市立心科学有限公司 | 2018-09-04 | — | — | CN | claimed |
| CN-107320782-A | Absorbable bio-medical lactic acid composite material and preparation method thereof | 深圳市立心科学有限公司 | 2017-11-07 | — | — | CN | claimed |
| US-11987567-B2 | Synthesis method of lactide by confinement effect catalysis of crystalline porous polymer material | QINGDAO UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) | 2024-05-21 | — | — | US | disclosed |
| US-20230094928-A1 | Synthesis method of lactide by confinement effect catalysis of crystalline porous polymer material | QINGDAO UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) | 2023-03-30 | — | — | US | disclosed |
| CN-113788937-A | Synthetic method of crystalline porous polymer material confined catalytic lactide | 青岛科技大学 | 2021-12-14 | — | — | CN | disclosed |
| CN-110068546-A | Lactide amount in quantifying polymers matrix | 普拉克生化公司 | 2019-07-30 | — | — | CN | disclosed |
| CN-105229436-B | Pressing detection device and touch panel | 三井化学株式会社 | 2019-06-28 | — | — | CN | disclosed |
| CN-104287797-B | For positioning and the method and apparatus of ligament graft fixation object | 美多斯国际有限公司 | 2019-06-18 | — | — | CN | disclosed |
| CN-105879119-B | A kind of compound acellular matrix hydrogel and preparation method thereof | 东华大学 | 2019-06-11 | — | — | CN | disclosed |
| CN-106084257-B | A kind of composite hydrogel and preparation method thereof | 东华大学 | 2019-04-16 | — | — | CN | disclosed |
| CN-101555243-A | Manufacturing method and device of cyclic refined lactic acid dimmer and manufacturing method and device of polylactic acid | HITACHI PLANT TECHNOLOGIES LTD (JP) | 2009-10-14 | — | — | CN | disclosed |
| US-6114495-A | POLYLACTIDE POLYMER HAVING A NUMBER AVERAGE MOLECULAR WEIGHT OF BETWEEN ABOUT 25,000 AND ABOUT 200,000, LACTIDE, IF PRESENT AT ALL, PRESENT IN CONCENTRATION OF LESS THAN 0.5 WT % BASED ON WEIGHT OF COMPOSITION, DEACTIVATING AGENTS | CARGILL INCORPORATED (US) | 2000-09-05 | — | — | US | disclosed |
| US-5686546-A | CONTAINER LININGS | AT PLASTICS, INC. (CA) | 1997-11-11 | — | — | US | disclosed |
| US-5618911-A | RING OPENING POLYMERIZING LACTONE IN THE PRESENCE OF ALIPHATIC CARBOXYLIC ACID; BIODEGRADABILITY | TOYO BOSEKI KABUSHIKI KAISHA (JP) | 1997-04-08 | — | — | US | disclosed |
| EP-0722469-A1 | CONTINUOUS PROCESS FOR THE MANUFACTURE OF LACTIDE AND LACTIDE POLYMERS | CARGILL, INCORPORATED (US) | 1996-07-24 | — | — | EP | disclosed |
| WO-1995009879-A1 | CONTINUOUS PROCESS FOR THE MANUFACTURE OF LACTIDE AND LACTIDE POLYMERS | CARGILL, INCORPORATED (US) | 1995-04-13 | — | — | WO | disclosed |
| US-5366734-A | Implantable or injectable composition with polylactide or copolymer with glycolic acid with polypeptides for sustained release | ZENECA LIMITED (GB) | 1994-11-22 | — | — | US | disclosed |
| US-5004602-A | Containing Polypeptides | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1991-04-02 | — | — | US | disclosed |
| US-4767628-A | POLYLACTONE AND ACID STABLE POLYPEPTIDE | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1988-08-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230094928-A1 | Synthesis method of lactide by confinement effect catalysis of crystalline porous polymer material | LCT, LDHB, LDHA | CA1 34/4885CA9 17/4885SMN1; SMN2 3358/4885 |
| US-11987567-B2 | Synthesis method of lactide by confinement effect catalysis of crystalline porous polymer material | LCT, LDHB, LDHA | CA1 34/4885CA9 17/4885SMN1; SMN2 3358/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.